CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 24 enrolled
Drug / intervention
Viagradrug
Likely dose
Viagra 100mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00199563
NCT00199563Phase 4Completed

The Use and Efficacy of Sildenafil in Diabetic Men With Erectile Dysfunction: the Impact on Endothelial Function, a Pilot Feasibility Study

In Brief

A Phase 4 clinical trial evaluating Viagra for Impotence. Completed, enrolled 24 participants across 1 site.

Detailed Summary

* To evaluate the impact of nightly sildenafil vs placebo use on diabetic men with and without proven endothelial dysfunction and coexisting erectile concerns. * To determine if chronic sildenafil use compared to placebo positively impacts endothelial function among a cohort of diabetic mend with erectile dysfunction * To assess the salvage rate of sildenafil - failures who demonstrate improved response rates over time with chronic use * To assess if microalbuminuria predicts flow-mediated dilation (FMD) response * To measure and identify if other patient specific characteristics predict for sildenafil erectile response and flow-mediated dilatation (FMD) response over time (patient specifics; blood pressure, HBA1c, weight, BMI, age IIEF score at baseline)

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsImpotence
CountriesCanada
Collaborators--

Timeline

Phase 4CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 20, 2005
Enrollment StartAug 1, 2004
Primary CompletionOct 1, 2007
Study CompletionDec 1, 2007
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 20.8 years ago

Interventions

Viagradrug

Sildenafil 100mg daily for 12 weeks